Cover Image

Spatial omics accelerate the study of cancer‐associated fibroblasts in non‐small lung cancer

Saved in:

Bibliographic Details
Main Authors:	Haozhen Liu (Author), Jixian Liu (Author), Chao Chen (Author)
Format:	Book
Published:	Wiley, 2024-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dissecting the brain with spatially resolved multi-omics
by: Yijia Fangma, et al.
Published: (2023)

The Cancer Omics Atlas: an integrative resource for cancer omics annotations
by: Qingrong Sun, et al.
Published: (2018)

Deciphering breast cancer dynamics: insights from single-cell and spatial profiling in the multi-omics era
by: Xin Xiong, et al.
Published: (2024)

GPX8+ cancer-associated fibroblast, as a cancer-promoting factor in lung adenocarcinoma, is related to the immunosuppressive microenvironment
by: Ying Bai, et al.
Published: (2024)

Correction to: The Cancer Omics Atlas: an integrative resource for cancer omics annotations
by: Qingrong Sun, et al.
Published: (2018)

MERTK Inhibition: Potential as a Treatment Strategy in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer
by: Chao-Ju Chen, et al.
Published: (2021)

Current status of immunotherapy for non-small cell lung cancer
by: Tao Yang, et al.
Published: (2022)

Biomarkers for cancer-associated fibroblasts
by: Chencheng Han, et al.
Published: (2020)

Extracellular Vesicles Derived from Lung Cancer Cells Induce Transformation of Normal Fibroblasts into Lung Cancer-Associated Fibroblasts and Promote Metastasis of Lung Cancer by Delivering lncRNA HOTAIR
by: Xiaoxuan Zhang, et al.
Published: (2022)

Retracted: Extracellular Vesicles Derived from Lung Cancer Cells Induce Transformation of Normal Fibroblasts into Lung Cancer-Associated Fibroblasts and Promote Metastasis of Lung Cancer by Delivering lncRNA HOTAIR
by: Stem Cells International
Published: (2024)

Recent progress in targeted therapy for non-small cell lung cancer
by: Yanxia Xiao, et al.
Published: (2023)

Mechanism of TCF21 Downregulation Leading to Immunosuppression of Tumor-Associated Macrophages in Non-Small Cell Lung Cancer
by: Hong Liu, et al.
Published: (2023)

Using Cancer 'Omics' to Understand Cancer
Published: (2020)

Sintilimab for the treatment of non-small cell lung cancer
by: Lin Zhang, et al.
Published: (2022)

Chemoresistance factors in non-small cell lung cancer
by: А. I. Shevchenko, et al.
Published: (2016)

Single-cell and spatially resolved omics: Advances and limitations
by: Jiaye Chen, et al.
Published: (2023)

Advances in targeting cancer-associated fibroblasts through single-cell spatial transcriptomic sequencing
by: Pin Lyu, et al.
Published: (2024)

Association between immune-related adverse events and immunotherapy efficacy in non-small-cell lung cancer: a meta-analysis
by: Li Lin, et al.
Published: (2023)

Function-Wise Dual-Omics analysis for radiation pneumonitis prediction in lung cancer patients
by: Bing Li, et al.
Published: (2022)

Genetic Association of Drug Response to Erlotinib in Chinese Advanced Non-small Cell Lung Cancer Patients
by: Cong Wang, et al.
Published: (2018)

The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancer
by: Yue Pan, et al.
Published: (2022)

Recent progress of small-molecule of RET inhibitors against Non-small cell lung cancer
by: Jiayi Shen, et al.
Published: (2024)

Promise of spatially resolved omics for tumor research
by: Yanhe Zhou, et al.
Published: (2023)

Non-Small-Cell Lung Cancer. Unusual Small Bowel Metastasis with Invagination
by: Miguel Ángel Serra Valdés, et al.
Published: (2017)

Non-Small-Cell Lung Cancer. Unusual Small Bowel Metastasis with Invagination
by: Miguel Ángel Serra Valdés, et al.
Published: (2017)

Editorial: Multi-omics approaches for decoding heterogeneity in cancer immunotherapy
by: Aimin Jiang, et al.
Published: (2023)

METTL7B Is Required for Cancer Cell Proliferation and Tumorigenesis in Non-Small Cell Lung Cancer
by: Dongcheng Liu, et al.
Published: (2020)

Osimertinib as Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: A Case Series
by: Yan Hu, et al.
Published: (2022)

The coexpression of multi-immune inhibitory receptors on T lymphocytes in primary non-small-cell lung cancer
by: Guo WJ, et al.
Published: (2017)

Anticancer Effects of Amlodipine Alone or in Combination With Gefitinib in Non-Small Cell Lung Cancer
by: Bingjie Fu, et al.
Published: (2022)

PARP-1 genetic polymorphism associated with radiation sensitivity of non-small cell lung cancer
by: Hetong Wang, et al.
Published: (2022)

PHARMACOECONOMIC ASPECTS OF NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY
by: A. V. Rudakova, et al.
Published: (2017)

Iterative surgical resections in non-small cell lung cancer
by: Ahmet Ucvet, et al.
Published: (2022)

Therapeutic Implications of PTEN in Non-Small Cell Lung Cancer
by: Zaid Sirhan, et al.
Published: (2023)

Inhaled Medicines for Targeting Non-Small Cell Lung Cancer
by: Arwa Omar Al Khatib, et al.
Published: (2023)

First line Immunotherapy for Non-Small Cell Lung Cancer
by: Nicola J. Nasser, et al.
Published: (2020)

The inhibitory effect of dihydroartemisinin on non-small cells lung cancer
by: Yan Li, et al.
Published: (2021)

Biogenesis, functions, and clinical implications of circular RNAs in non-small cell lung cancer
by: Ying Liu, et al.
Published: (2022)

Skin manifestations of gefitinib and the association with survival of advanced non-small-cell lung cancer in Taiwan
by: Shiou-Han Wang, et al.
Published: (2011)

GSK-3β inhibits autophagy and enhances radiosensitivity in non-small cell lung cancer
by: Jialin Ren, et al.
Published: (2018)